Instruction to Authors

The Journal of Ankara Universty Faculty Medicine is published quarterly (April, August, December). It aims to publish research articles, invited reviews and case reports on Basic, Medical and Surgical sciences.

The abbreviation of the Journal of Ankara Universty Faculty Medicine is J Ankara Univ Fac Med.

The Journal of Ankara Universty Faculty Medicine does not charge any article submission, processing or publication charges.

The scientific and ethical liability of the manuscripts belongs to the authors and the copyright of the manuscripts belongs to the Galenos Publishing House. Authors are responsible for the contents of the manuscript and accuracy of the references. All manuscripts submitted for publication must be accompanied by the Copyright Transfer Form. Once this form, signed by all the authors, is submitted, it is understood that neither the manuscript nor the data it contains have been submitted elsewhere or previously published and authors declare the statement of scientific contributions and responsibilities of all authors. Abstracts presented at congresses are eligible for evaluation.

The Editorial Policies and General Guidelines for manuscript preparation specified below are based on “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals” (ICMJE Recommendations) by the International Committee of Medical Journal Editors.


The Journal of Ankara Universty Faculty Medicine is an independent journal based on double-blind peer-review principles. The manuscript is assigned to the Editor-in-Chief, who reviews the manuscript and makes an initial decision based on manuscript quality and editorial priorities. Manuscripts that pass initial evaluation are sent to an Associate Editor. The Associate Editor assignes the manuscript to two reviewers (internal and/or external reviewers). The reviewers must review the manuscript within 21 days. The Associate Editor recommends a decision based on the reviewers’ recommendations and sends the manuscript to the Editor-in-Chief. The Editor-in-Chief makes a final decision based on editorial priorities, manuscript quality, and Associate Editor’s and reviewers’ recommendations. If there are any conflicting recommendations from reviewers, the Editor-in-Chief can assign a new reviewer.

All manuscripts submitted are screened for plagiarism using Crossref Similarity Check powered by “iThenticate” software. Results indicating plagiarism may cause manuscripts being returned or rejected.


Experimental, clinical and drug studies requiring approval by an ethics committee must be submitted to the Journal of Ankara Universty Faculty Medicine with an ethics committee approval report confirming that the study was conducted in accordance with international agreements and the Declaration of Helsinki. The approval of the ethics committee and the fact that informed consent was given by the patients should be indicated in the Patients and Methods section. In experimental animal studies, the authors should indicate that the procedures followed were in accordance with animal rights as per the Guide for the Care and Use of Laboratory Animals and they should obtain animal ethics committee approval.

Preparation of research articles, systematic reviews and meta-analyses must comply with study design guidelines:

CONSORT statement for randomized controlled trials

PRISMA statement of preferred reporting items for systematic reviews and meta-analyses

STARD checklist for the reporting of studies of diagnostic accuracy

STROBE statement, a checklist of items that should be included in reports of observational studies

MOOSE guidelines for meta-analysis and systemic reviews of observational studies

Authors must provide disclosure/acknowledgment of financial or material support, if any was received, for the current study.

If the article includes any direct or indirect commercial links or if any institution provided material support to the study, authors must state in the cover letter that they have no relationship with the commercial product, drug, pharmaceutical company, etc. concerned; or specify the type of relationship (consultant, other agreements), if any.

Authors must provide a statement on the absence of conflicts of interest among the authors and provide authorship contributions.

In case of any suspicion or claim regarding scientific shortcomings or ethical infringement, the Journal reserves the right to submit the manuscript to the supporting institutions or other authorities for investigation. The Journal accepts the responsibility of initiating action but does not undertake any responsibility for an actual investigation or any power of decision.


Manuscripts can only be submitted electronically through the Journal Agent website ( after creating an account.

Manuscripts written in Turkish should be in accordance with the Turkish Dictionary and Writing Guide (“Türkçe Sözlüğü ve Yazım Kılavuzu”) of the Turkish Language Association.

Format: Manuscripts should be prepared using Microsoft Word, size A4 with 2.5 cm margins on all sides, 12 pt Arial font and 1.5 line spacing.

Abbreviations: Abbreviations should be defined at first mention and used consistently thereafter. Internationally accepted abbreviations should be used; refer to scientific writing guides as necessary.

Cover letter: The cover letter should include statements about manuscript type, single-journal submission affirmation, conflict of interest statement, sources of outside funding, equipment (if applicable), approval of language for articles in English and approval of statistical analysis for original research articles.

Manuscript Types

All submitted articles must be accompanied by following files:

Title Page: This page should include the title of the manuscript, short title, name(s) of the authors and author information. The following descriptions should be stated in the given order:

  1. Title of the manuscript (Turkish and English), as concise and explanatory as possible, including no abbreviations, up to 12 words
  2. Short title (Turkish and English), up to 60 characters
  3. Name(s) and surname(s) of the author(s) (without abbreviations and academic titles) and affiliations
  4. Name, address, e-mail, phone and fax number of the corresponding author
  5. The place and date of scientific meeting in which the manuscript was presented and its abstract published in the abstract book, if applicable

Abstract: A summary of the manuscript should be written in both Turkish and English. Abstract should not exceed 250 words. References should not be cited in the abstract. Use of abbreviations should be avoided as much as possible; if any abbreviations are used, they must be taken into consideration independently of the abbreviations used in the text.

For original articles, the structured abstract should include the following sub-headings:

Objectives: The aim of the study should be clearly stated.

Materials and Methods: The study and standard criteria used should be defined; it should also be indicated whether the study is randomized or not, whether it is retrospective or prospective, and the statistical methods applied should be indicated, if applicable. 

Results: The detailed results of the study should be given and the statistical significance level should be indicated.

Conclusion: Should summarize the results of the study, the clinical applicability of the results should be defined, and the favorable and unfavorable aspects should be declared.

Keywords: A list of minimum 3, but no more than 5 keywords must follow the abstract. Keywords in English should be consistent with “Medical Subject Headings” (MESH). Turkish keywords should be direct translations of the terms in MESH.

Original Articles

Clinical research should comprise clinical observation, new techniques or laboratory studies. Original research articles should include title, structured abstract, keywords relevant to the content of the article, introduction, patients/materials and methods, results, discussion, references, tables/figures and acknowledgement sections. Title, abstract and keywords should be written in both Turkish and English. The manuscript should be formatted in accordance with the above-mentioned guidelines and should not exceed 3000 words.

Introduction: Should consist of a brief explanation of the topic and indicate the objective of the study, supported by information from the literature.

Materials and Methods: The study plan should be clearly described, indicating whether the study is randomized or not, whether it is retrospective or prospective, the number of trials, the characteristics, and the statistical methods used.

Results: The results of the study should be stated, with tables/figures given in numerical order; the results should be evaluated according to the statistical analysis methods applied.

Discussion: The study results should be discussed in terms of their favorable and unfavorable aspects and they should be compared with the literature. The conclusion of the study should be highlighted.

Acknowledgements: Any technical or financial support or editorial contributions (statistical analysis, English/Turkish evaluation) towards the study should appear at the end of the article.

References: The number of references should not exceed 40. Authors are responsible for the accuracy of the references. See References Section for details about the usage and formatting required.

Case Reports

Case reports should present cases which are rarely seen, feature novelty in diagnosis and treatment, and contribute to our current knowledge. The first page should include the title in Turkish and English, an unstructured abstract not exceeding 250 words, and keywords. The main text should not exceed 1500 words and consist of introduction, case presentation, discussion and references not exceeding 20.

Review Articles

The journal publishes invited reviews only. Review articles must provide critical analyses of contemporary evidence and provide directions of current or future research. Reviews articles analyze topics in depth, independently and objectively. The first page should include the title in Turkish and English, an unstructured abstract and keywords. Source of all citations should be indicated and references amount should not exceed 100. The main text should not exceed 5000 words.


Authors are responsible for the accuracy and completeness of their refences and for correct in-text citation. All references should be in accordance with following rules:

In-text citations: References should be indicated in the parentheses before the full stop of the relevant sentence. If the author(s) of a reference is/are indicated at the beginning of the sentence, this reference should be written in the parentheses immediately after the author’s name. If relevant research has been conducted in Turkey or by Turkish researchers, these studies should be given priority while citing the literature.

References section: References should be numbered consecutively in the order in which they are first mentioned in the text. If there are more than 3 authors, first 3 authors must be listed followed by “et al”. The titles of journals should be abbreviated according to the style used in the Index Medicus.

Reference Format

Journal: Schwarz DS, Blower MD. The endoplasmic reticulum: structure, function and response to cellular signaling. Cell Mol Life Sci. 2016;73:79-94.

Book: Tos M. Cartilage tympanoplasty. 1st ed. Stuttgart-New York: Georg Thieme Verlag; 2009.

Editor(s) compiler as author: Kurt N, editor. Yetişkinlerde ve Çocuklarda Ameliyat Öncesi Değerlendirme. Istanbul: Nobel Tıp Kitapevleri; 2002.

Book Chapter: Rowe JS. Liver. In: Skandalakis JE, Gray SW, Rowe JS, editors. Anatomical Complications in General Surgery. 1st ed. New York: McGraw-Hill Book Co; 1986. p. 103-124.

Conference Paper: Seyhan F. Kalça ekleminde yüzey değiştirme artroplastisinin (Wagner protezi) geç sonuçları. In: Ege R, editor. X. Milli Türk Ortopedi ve Travmatoloji Kongre Kitabı; 17-20 Mayıs, 1987; Mersin, Türkiye. Ankara: Emel; 1989. p. 494-6. (Unpublished conference paper should not be used as a reference).

Computer Software: StatView SE+Graphics [computer program] Version 1.03. Berkley: Abacus Concepts İnc.; 1988.

Figures and Tables

All visual materials (pictures, graphs and drawn figures) must be named as “Figure”. All figures and tables must be cited within the main text consecutively. Legends of all figures must be submitted as separate page of main document. Each figure must be submitted as separate file and in “.jpeg” format. All figures shoud be of the possible highest quality and at a minimum resolution of 300 dpi. All figures must be original. Figures previously published by other sources, must be submitted with a copy of written permission of the owner of figure. All permissions must be obtained by authors prior to submission. For figures involved human studies, written informed consent must be taken from patient or his/her parent and uploaded during submission. Otherwise, patient’s names must not be indicated and their eyes must be hided with black lines to prevent any exposure of identity. Used stain and zoom rate must be indicated in microscobic figures.

All tables should be added to the main document or to the separate file. Tables added within the main document must be placed as each in separate page after the reference list with descriptive title above the table. Titles of tables added to the separate file must be indicated within the main text on separate page.

Informed Consent and Ethics

Manuscript repoting the results of experimental investigations on human subjects must include a statement in the Patients and Methods section that the institutional review board has approved the study and the informed consent were obtained from patient or parents. The authour(s) should state the accordance to the Declaration of Helsinki and “Regulations in drug research Ministry of Health,Goverment of Turkey, January 29,1993’’. Also, the experimental studies must be approved by the ethics commitee for animal use and proper ethics.


Prof. Dr. K. Osman Memikoğlu

Ankara Üniversitesi Tıp Fakültesi,

Yayın Komisyonluğu Başkanlığı

06100 Sıhhıye, ANKARA


Phone: + 90 312 595 82 07

Fax: + 90 312 310 69 40